Chul Kim
Georgetown University · 269 works · 3,949 citations · h-index 34
Top works
- Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic
- Nest building, general activity, and salt preference of rats following hippocampal ablation.
- Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
- Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs
- Sexual activity of male rats following ablation of hippocampus.
- Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer
- Influence of Ginseng on Mating Behavior of Male Rats
- Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
- Adiponectin Levels and the Risk of Hypertension
- Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers
- Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
- Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non–Small Cell Lung Cancer
- A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
- Oral Chemotherapy for Treatment of Lung Cancer
- Metastatic lymphoepithelioma-like carcinoma of the lung treated with nivolumab: a case report and focused review of literature
- Influence of hippocampectomy on gastric ulcer in rats
- A Multicenter Retrospective Analysis of Adverse Events in Korean Patients Using Bortezomib for Multiple Myeloma
- Reliability importance for continuum structure functions
- A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor–Naïve EGFR -Mutant Metastatic Non–Small Cell Lung Cancer (RAMOSE trial)
- Crystal and Molecular Structure of 5-(Bromomethylene)-10,11-dihydro-5H-dibenzo[a,d]-cycloheptene.